Medicine & Surgery
Rotavac: indigenous rotavirus vaccine
licensed 2014; WHO-prequalified 2018Bharat Biotech with public partnersRotavacDelhi
2014
A low-cost oral vaccine against rotavirus diarrhoea developed largely in India.
- Dated
- 2014–2018
- As scholars put it
- licensed 2014; WHO-prequalified 2018
- Originator
- Bharat Biotech with public partners
- Source text
- Rotavac
- Region
- Delhi
- Discipline
- Medicine & Surgery
- Evidence
- Documented
- Confidence
- High
- Verification
- Reference-cited
Fair to say
Built on a strain first isolated in Delhi; developed with international partners.
Path to modern innovation
Cuts child deaths from diarrhoeal disease.
Builds on
1892Transmission
Used in India's national immunisation programme and abroad.
References
- 1Bhandari et al., Lancet (2014)
Further reading
Related
Corrections and additional sources: edit IND-282 on GitHub.